Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
0.559
-0.083 (-12.91%)
Aug 12, 2022 2:40 PM EDT - Market open

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016201520142013
Cash & Equivalents
19.1414.4634.487.8535.9548.7534.440.182.12
Short-Term Investments
040.010000000
Cash & Cash Equivalents
19.1454.4734.487.8535.9548.7534.440.182.12
Cash Growth
-64.86%57.98%339.17%-78.16%-26.25%41.74%-14.40%1795.69%-
Receivables
1.530.870000000
Inventory
0.9700000000
Other Current Assets
2.281.450.840.610.762.773.690.80.15
Total Current Assets
23.9356.7935.328.4636.7151.5238.0940.992.27
Property, Plant & Equipment
13.414.3814.213.9313.8612.3312.3212.0511.96
Other Long-Term Assets
2.011.90.0200.020.020.021.790.18
Total Long-Term Assets
15.4116.2814.2213.9313.8812.3512.3413.8412.14
Total Assets
39.3373.0649.5422.3950.663.8750.4254.8314.41
Accounts Payable
8.713.871.820.882.782.052.392.630.72
Current Debt
16.8300010.615.12.3455.11
Other Current Liabilities
3.743.491.981.340.883.823.061.361.02
Total Current Liabilities
29.287.353.82.2214.2710.977.788.996.84
Long-Term Debt
0.7816.3800010.6112.99.839.77
Other Long-Term Liabilities
00---00069.23
Total Long-Term Liabilities
0.7816.3800010.6112.99.8379
Total Liabilities
30.0623.733.82.2214.2721.5820.6818.8285.85
Total Debt
17.6216.380010.6115.7115.2314.8314.87
Debt Growth
7.54%----32.49%3.15%2.70%-0.29%-
Common Stock
396.39361.55306.12261.73258.1235.76194.47170.446.87
Retained Earnings
-387.12-312.22-260.37-241.55-221.77-193.47-164.73-134.39-118.31
Comprehensive Income
000000000
Shareholders' Equity
9.2749.3345.7520.1736.3242.2929.7436.01-71.44
Total Liabilities and Equity
39.3373.0649.5422.3950.663.8750.4254.8314.41
Net Cash / Debt
1.5338.0934.487.8525.3533.0419.1625.35-12.76
Net Cash / Debt Growth
-95.99%10.47%339.17%-69.02%-23.29%72.41%-24.41%--
Net Cash Per Share
0.6317.9927.909.1532.7746.7434.8188.99-10311.47
Working Capital
-5.3549.4331.526.2422.4440.5530.331.99-4.58
Book Value Per Share
3.8223.3037.0223.5246.9659.8354.04126.39-57.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).